The U.S. Food and Drug Administration, now, allows remdesivir (brand name, Veklury) to be used for the treatment of all hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19.
The U.S. Food and Drug Administration, now, allows remdesivir (brand name, Veklury) to be used for the treatment of all hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19.